Joan How

874 citations

39 papers · 543 indexed · h-index 14

Impact in

Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation

Papers in ⓘ

Genetics 30
- Myeloproliferative Neoplasms: Diagnosis and Treatment 29
Rheumatology 21
- Eosinophilic Disorders and Syndromes 20

Co-authors: Gabriela Hobbs (24 shared papers)Ann Mullally (4 shared papers)Stephen T. Oh (3 shared papers)Amy Zhou (1 shared paper)Suzanne E. Schindler (1 shared paper)Susan A. Fowler (1 shared paper)Jacqueline S. Garcia (1 shared paper)Andrea Wang‐Gillam (1 shared paper)
Journals: Blood (8 papers)Blood Advances (2 papers)Hematology (2 papers)Journal of the National Comprehensive Cancer Network (2 papers)JACC CardioOncology (1 paper)
Partner nations: United States Netherlands

In The Last Decade

Joan How

35 papers receiving 537 citations

Peers

Countries citing papers authored by Joan How

Since Specialization

Citations

This map shows the geographic impact of Joan How's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan How with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan How more than expected).

Fields of papers citing papers by Joan How

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan How. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan How. The network helps show where Joan How may publish in the future.

Co-authors

The 25 scholars most cited alongside Joan How, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joan How Line = papers co-authored together Joan How links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutant calreticulin in myeloproliferative neoplasms Blood ·Joan How, Gabriela Hobbs, Ann Mullally	2019	55
2	Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome The Neurologist ·Joan How, Margaret Blattner, Susan A. Fowler, Andrea Wang‐Gillam, Suzanne E. Schindler	2016	51
3	What are the links between maternal social status, hippocampal function, and HPA axis function in children? Developmental Science ·Margaret A. Sheridan, Joan How, Melanie Araujo, Michelle A. Schamberg, Charles A. Nelson	2013	45
4	Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature Cancers ·Joan How, Gabriela Hobbs	2020	44
5	Pulsatile Erlotinib in EGFR-Positive Non–Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature Clinical Lung Cancer ·Joan How, Janelle Mann, Andrew N. Laczniak, Maria Q. Baggstrom	2017	41
6	Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease Therapeutic Advances in Hematology ·Joan How, Amy Zhou, Stephen T. Oh	2016	39
7	Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation Laboratory Investigation ·Mei‐Yu Hsu, Sherry A. Rovinsky, Chiou-Yan Lai, Shadi Qasem, Xiaoming Liu, Joan How, John F. Engelhardt, Gëorge F. Murphy	2008	37
8	Biology and therapeutic targeting of molecular mechanisms in MPNs Blood ·Joan How, Jacqueline S. Garcia, Ann Mullally	2022	31
9	T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia Biology of Blood and Marrow Transplantation ·Joan How, Michael Slade, Khoan Vu, John F. DiPersio, Peter Westervelt, Geoffrey L. Uy, Camille N. Abboud, Ravi Vij, Mark A. Schroeder, Todd A. Fehniger, Rizwan Romee	2017	30
10	Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis British Journal of Haematology ·Joan How, Kathryn Trinkaus, Stephen T. Oh	2017	25
11	Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia Leukemia Research ·Joan How, Orly Leiva, Thomas Bogue, Geoffrey Fell, Mark Bustoros, Nathan T. Connell, Jean M. Connors, Irene M. Ghobrial, David J. Kuter, Ann Mullally, Donna Neuberg, Jeffrey I. Zwicker, Annemarie E. Fogerty, Gabriela Hobbs	2020	22
12	Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients Blood Cancer Journal ·Joan How, Charlotte Story, Siyang Ren, Donna Neuberg, Rachel Rosovsky, Gabriela Hobbs, Jean M. Connors	2021	18
13	Moving toward disease modification in polycythemia vera Blood ·Jan Philipp Bewersdorf, Joan How, Lucia Masárová, Prithviraj Bose, Naveen Pemmaraju, John Mascarenhas, Raajit K. Rampal	2023	16
14	Blast and accelerated phase CML: room for improvement Hematology ·Joan How, Vinayak Venkataraman, Gabriela Hobbs	2021	14
15	Are Nectarines to Blame? A Case Report and Literature Review of Spontaneous Bacterial Peritonitis Due to Listeria monocytogenes. PubMed ·Joan How, Marwan M. Azar, Jaimie P. Meyer	2015	13
16	Evaluation of a Pan-Lysyl Oxidase Inhibitor, Pxs-5505, in Myelofibrosis: A Phase I, Randomized, Placebo Controlled Double Blind Study in Healthy Adults Blood ·Joan How, Yiwen Liu, Jennifer Lombardi Story, Donna Neuberg, Katya Ravid, Wolfgang Jarolimek, Brett Charlton, Gabriela Hobbs	2020	10
17	A Practical Guide for Using Myelofibrosis Prognostic Models in the Clinic Journal of the National Comprehensive Cancer Network ·Joan How, Gabriela Hobbs	2020	9
18	Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer Histochemistry and Cell Biology ·Joan How, Jason R. Brown, Sasha Saylor, David L. Rimm	2014	8
19	Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera Current Hematologic Malignancy Reports ·Joan How, Gabriela Hobbs	2021	5
20	Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis Blood Advances ·Rathnam Venkat, Robert Redd, Amyah C. Harris, Martin J. Aryee, Anna E. Marneth, Baransel Kamaz, Chulwoo J. Kim, Mohammed Wazir, Lachelle D. Weeks, Maximilian Stahl, Daniel J. DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela Hobbs, Joan How	2024	3

About Joan How

Joan How is a scholar working on Genetics, Rheumatology, Hematology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 39 papers that have together received 543 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (29 papers), Eosinophilic Disorders and Syndromes (20 papers), Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (8 papers), Kruppel-like factors research (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Pregnancy and preeclampsia studies (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Genetics (270 citations), Hematology (199 citations), Rheumatology (186 citations), Internal Medicine (18 citations) and Behavioral Neuroscience (16 citations). Joan How has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Gabriela Hobbs, Ann Mullally, Stephen T. Oh, Amy Zhou, Suzanne E. Schindler, Susan A. Fowler, Jacqueline S. Garcia, Andrea Wang‐Gillam, Maria Q. Baggstrom and Janelle Mann. Their work appears in journals such as Blood, Blood Advances, Hematology, Journal of the National Comprehensive Cancer Network and JACC CardioOncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact